Beta Drugs Ltd.
| BSE: 535022 | Sector: Health care |
| NSE: BETA | ISIN Code: INE351Y01019 |
| BSE 05:30 | 01 Jan | Beta Drugs Ltd |
| NSE 00:00 | 12 May | 241.20 |
11.45 (4.98%) |
OPEN
241.20 |
HIGH
241.20 |
LOW
241.20 |
| OPEN | |
| PREVIOUS CLOSE | |
| VOLUME | |
| 52-Week high | 0.00 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 0 |
| Buy Price | |
| Buy Qty | |
| Sell Price | |
| Sell Qty |
Beta Drugs Ltd. (BETA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 702.65 | -5.20 | -0.73 | 3211.14 |
| Dr Reddy's Labs | 5302.00 | 8.40 | 0.16 | 2937.70 |
| Cipla | 898.70 | 7.95 | 0.89 | 2318.17 |
| Aurobindo Pharma | 1016.25 | -14.55 | -1.41 | 1872.74 |
| Cadila Health. | 646.95 | 17.25 | 2.74 | 1412.90 |
| Divi's Lab. | 4061.25 | -13.40 | -0.33 | 1372.71 |
| Glenmark Pharma. | 623.85 | -0.70 | -0.11 | 1354.55 |
| Alkem Lab | 2994.65 | -37.70 | -1.24 | 1264.42 |
| Alembic Pharma | 950.90 | -1.85 | -0.19 | 969.40 |
| Torrent Pharma. | 2725.65 | 10.75 | 0.40 | 938.51 |
| Gland Pharma | 2858.60 | -7.55 | -0.26 | 772.86 |
| Lupin | 1210.75 | 13.15 | 1.10 | 727.55 |
| Ipca Labs. | 2136.55 | -23.65 | -1.09 | 652.46 |
| Abbott India | 16114.80 | -78.75 | -0.49 | 592.93 |
| Fortis Health. | 230.70 | -5.45 | -2.31 | 513.33 |
| Pfizer | 5347.80 | -53.90 | -1.00 | 509.13 |
| Sanofi India | 7751.10 | -102.25 | -1.30 | 477.60 |
| Natco Pharma | 924.05 | -3.10 | -0.33 | 474.50 |
| Apollo Hospitals | 3196.50 | -62.80 | -1.93 | 470.30 |
| Granules India | 336.50 | -23.40 | -6.50 | 444.07 |
Quick Links for Beta Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
